Zhen Huang
Director/Board Member chez WALVAX BIOTECHNOLOGY CO., LTD.
Fortune : 66 M $ au 31/03/2024
Profil
Zhen Huang currently works at Walvax Biotechnology Co., Ltd., as Vice Chairman from 2019, Shanghai Zerun Biotechnology Co., Ltd., as Director, and Yuxi Walvax Biotechnology Co., Ltd., as President.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 17 698 729 ( 1,14% ) | 38 M $ | 31/03/2024 | |
| 30/09/2023 | 13 274 047 ( 28,09% ) | 28 M $ | 31/03/2024 |
Postes actifs de Zhen Huang
| Sociétés | Poste | Début |
|---|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Director/Board Member | 22/08/2019 |
| Yuxi Walvax Biotechnology Co., Ltd. | President | - |
Shanghai Zerun Biotechnology Co., Ltd.
 Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Yuxi Walvax Biotechnology Co., Ltd. | |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Health Technology |
